Michael Williams is a senior pharmaceutical executive with significant global experience. He was chief operating officer at Intarcia Therapeutics. Prior to Intarcia Therapeutics, Mr Williams was head of global marketing at Takeda Pharmaceuticals. Before joining Takeda, he was vice president of global commercial development for Pfizer’s Primary Care Global Business Unit. He also played a significant leadership role in Pfizer’s acquisition of King Pharmaceuticals and on alliances with Bristol Myers Squibb, Boehringer Ingelheim, Janssen and Eisai. During his time at Bristol Myers Squibb, he assumed roles of increasing responsibility, notably as regional business lead for HIV where he was responsible for the commercial performance of the HIV franchise, as well as vice president for European marketing and operations.